APGE - Apogee Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$109.44
DETAILS
HIGH:
$140.00
LOW:
$83.00
MEDIAN:
$103.00
CONSENSUS:
$109.44
UPSIDE:
34.84%
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.4 | (0.4) | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.4) | 0.4 | (0.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||||||||||||||
| R&D Expenses | 60.8 | 58.4 | 54.2 | 55.7 | 46.4 | 60.2 | 45.7 | 33.2 | 28.7 | 29.0 | 17.1 | 13.9 | 8.5 | 12.2 | 9.9 | 1.4 | 4.2 |
| SG&A Expenses | 21.5 | 20.1 | 17.1 | 17.1 | 16.6 | 15.7 | 13.0 | 10.9 | 9.5 | 8.2 | 7.2 | 4.9 | 4.2 | 1.9 | 0.6 | 0.4 | 0.1 |
| Other Expenses | 0 | (0.1) | (0.4) | 0.3 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 82.4 | 78.5 | 70.9 | 73.2 | 63.1 | 75.9 | 58.7 | 44.1 | 38.2 | 37.2 | 24.3 | 18.9 | 12.7 | 14.1 | 10.5 | 1.8 | 4.3 |
| Operating Income | |||||||||||||||||
| Operating Income | (82.8) | (78.1) | (71.3) | (73.2) | (63.1) | (75.9) | (58.7) | (44.1) | (38.2) | (37.2) | (24.3) | (18.9) | (12.7) | (14.1) | (10.5) | (1.8) | (4.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.2 | 0 | 0 |
| Interest Income | 8.7 | (21.3) | 6.3 | 7.1 | 7.8 | 8.7 | 9.7 | 10.3 | 6.1 | 5.4 | 3.5 | 0 | 0.1 | 0.1 | 0 | 0 | 0 |
| Profitability | |||||||||||||||||
| EBITDA | (82.4) | (77.7) | (64.6) | (72.8) | (62.9) | (75.8) | (58.6) | (44.1) | (38.2) | (31.7) | (20.8) | 0 | 0 | (14.0) | 0 | 0 | 0 |
| EBIT | (82.8) | (78.1) | (65.0) | (73.2) | (63.1) | (75.9) | (58.7) | (44.1) | (38.2) | (31.7) | (20.8) | (18.9) | (12.7) | (14.0) | (10.5) | (1.8) | (4.3) |
| Income Before Tax | (74.0) | (69.3) | (65.0) | (66.0) | (55.3) | (67.2) | (49.0) | (33.8) | (32.1) | (31.7) | (20.8) | (18.9) | (12.5) | (14.0) | (19.7) | (1.8) | (4.3) |
| Income Tax Expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (74.1) | (69.4) | (65.0) | (66.1) | (55.3) | (67.2) | (49.0) | (33.8) | (32.1) | (31.7) | (20.8) | (18.9) | (12.5) | (14.0) | (19.7) | (1.8) | (4.3) |
| Per Share Data | |||||||||||||||||
| EPS (Basic) | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.22 | -0.86 | -0.60 | -0.64 | -0.63 | -0.41 | -0.37 | -0.25 | -0.28 | -0.39 | -0.04 | -0.09 |
| EPS (Diluted) | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.22 | -0.86 | -0.60 | -0.64 | -0.63 | -0.41 | -0.37 | -0.25 | -0.28 | -0.39 | -0.04 | -0.09 |
| Shares Outstanding | 69.7 | 60.7 | 58.8 | 58.4 | 58.2 | 55.2 | 56.8 | 56.5 | 50.2 | 50.7 | 50.7 | 50.7 | 50.7 | 50.7 | 50.7 | 50.7 | 50.7 |
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||
| Cash & Cash Equivalents | 451.8 | 131.5 | 107.9 | 124.2 | 106.9 | 141.8 | 118.8 | 307.3 | 485.5 | 118.3 | 188.3 | 125.1 | 141.3 | 151.9 |
| Short-Term Investments | 608.1 | 598.6 | 419.4 | 381.2 | 406.4 | 378.9 | 407.3 | 368.9 | 330.7 | 277.1 | 234.6 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 4.5 | 4.1 | 5.0 | 4.7 | 4.8 | 0 | 0 | 1.2 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 13.9 | 11.2 | 0.9 | 1.0 | 0.6 | 1.7 | 0.4 | 3.4 | 2.7 | 0 | 1.4 | 4.4 | 0.5 | 0.1 |
| Total Current Assets | 1,073.8 | 741.4 | 540.1 | 516.1 | 521.5 | 529.7 | 534.5 | 681.9 | 820.6 | 398.4 | 426.4 | 130.7 | 142.0 | 152.1 |
| Non-Current Assets | ||||||||||||||
| Property, Plant & Equipment | 13.0 | 14.4 | 15.7 | 17.0 | 17.2 | 13.3 | 13.5 | 4.9 | 2.6 | 2.6 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 61.6 | 115.8 | 168.1 | 210.4 | 227.7 | 113.4 | 0.3 | 0.3 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 206.9 | 181.4 | 8.7 | 8.9 | 7.3 | 0.5 | 0.5 | 0.5 | 0.1 | 0.1 | 0.2 | 0 | 0 | 0 |
| Total Non-Current Assets | 219.9 | 195.8 | 86.1 | 141.7 | 192.6 | 224.2 | 241.8 | 118.8 | 3.1 | 3.0 | 0.2 | 0 | 0 | 0 |
| Total Assets | 1,293.7 | 937.1 | 626.2 | 657.8 | 714.2 | 754.0 | 776.3 | 800.7 | 823.7 | 401.4 | 426.4 | 130.7 | 142.0 | 152.1 |
| Current Liabilities | ||||||||||||||
| Account Payables | 1.2 | 1.2 | 0.4 | 5.7 | 2.4 | 1.1 | 2.2 | 5.5 | 4.3 | 2.1 | 1.2 | 11.1 | 1.0 | 0.4 |
| Short-Term Debt | 3.1 | 3.5 | 0 | 4.0 | 4.0 | 3.2 | 2.9 | 1.7 | 1.1 | 1.1 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 28.6 | 23.2 | 12.7 | 13.7 | 21.3 | 22.4 | 20.6 | 13.4 | 13.8 | 17.1 | 13.7 | 0.9 | 0.3 | 0 |
| Total Current Liabilities | 33.0 | 27.9 | 34.0 | 31.6 | 33.0 | 28.6 | 32.6 | 24.6 | 21.6 | 20.6 | 17.2 | 17.6 | 11.2 | 10.0 |
| Non-Current Liabilities | ||||||||||||||
| Long-Term Debt | 4.9 | 5.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 4.9 | 5.3 | 5.8 | 6.8 | 7.8 | 8.6 | 9.3 | 2.4 | 0.6 | 0.9 | 0 | 0 | 0 | 0 |
| Total Liabilities | 37.9 | 33.3 | 39.8 | 38.4 | 40.8 | 37.2 | 41.9 | 27.0 | 22.2 | 21.5 | 17.2 | 17.6 | 11.2 | 10.0 |
| Stockholders' Equity | ||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 | 6.8 | 2.3 | 2.3 |
| Retained Earnings | (635.9) | (561.8) | (492.4) | (427.4) | (361.3) | (305.9) | (238.7) | (189.7) | (155.9) | (123.8) | (92.0) | (71.2) | (52.3) | (39.8) |
| Accumulated Other Comprehensive Income | (0.7) | 1.1 | 1.0 | 0.7 | 1.1 | 0.9 | 3.3 | (0.3) | (0.2) | 0.3 | 0.1 | 4.5 | 3.4 | 2.1 |
| Total Stockholders' Equity | 1,255.8 | 903.9 | 586.3 | 619.4 | 673.4 | 716.8 | 734.4 | 773.6 | 801.5 | 379.9 | 409.2 | 113.1 | 130.8 | 142.1 |
| Total Liabilities & Equity | 1,293.7 | 937.1 | 626.2 | 657.8 | 714.2 | 754.0 | 776.3 | 800.7 | 823.7 | 401.4 | 426.4 | 130.7 | 142.0 | 152.1 |
| Debt Metrics | ||||||||||||||
| Total Debt | 8.0 | 8.8 | 9.9 | 10.8 | 11.8 | 11.8 | 12.1 | 4.1 | 1.8 | 2.0 | 0 | 0 | 0 | 0 |
| Net Debt | (443.8) | (122.7) | (98.1) | (113.3) | (95.1) | (130.0) | (106.6) | (303.2) | (483.7) | (116.3) | (188.3) | (125.1) | (141.3) | (151.9) |
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||
| Net Income | (74.1) | (69.4) | (65.0) | (66.1) | (55.3) | (67.2) | (49.0) | (33.8) | (32.1) | (31.7) | (20.8) | (18.9) | (12.5) | (14.0) | (19.7) | (1.8) | (4.3) |
| Depreciation & Amortization | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 17.2 | 11.9 | 11.9 | 11.3 | 11.1 | 7.6 | 5.8 | 5.7 | 4.2 | 2.2 | 1.5 | 1.1 | 1.3 | 2.1 | 0 | 0 | 0 |
| Change in Working Capital | 1.5 | (4.9) | (0.8) | (6.8) | (2.9) | (6.0) | 3.7 | 1.5 | (1.3) | 2.5 | (0.3) | 3.2 | 0.7 | 2.1 | 3.3 | 1.6 | 2.6 |
| Other Non-Cash Items | (0.6) | (0.8) | (0.7) | (0.8) | (1.5) | (2.2) | (3.1) | (2.8) | (2.4) | (2.8) | (0.2) | 0 | 0 | 0.6 | 9.2 | 0.2 | 1.7 |
| Operating Cash Flow | (55.6) | (62.7) | (54.3) | (62.0) | (48.5) | (67.7) | (42.5) | (29.3) | (31.6) | (29.8) | (19.9) | (14.6) | (10.6) | (9.2) | (7.2) | 0 | 0 |
| Investing Activities | |||||||||||||||||
| Capital Expenditure | 0 | (0.1) | 0 | (0.8) | (4.3) | 0.0 | (0.8) | (0.1) | (0.4) | (0.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (183.2) | (389.1) | (107.6) | (47.4) | (98.2) | (60.6) | (236.0) | (227.0) | (125.9) | (69.5) | (234.2) | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 147.9 | 100.5 | 125.6 | 126.3 | 115.5 | 107.0 | 90.4 | 78.3 | 74.5 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (234.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (35.3) | (288.6) | 17.9 | 78.1 | 13.0 | 46.4 | (146.4) | (148.7) | (51.7) | (273.9) | (234.2) | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | |||||||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 1.7 | 0 | 0 | 168.3 | 0 | (0.0) | 0 |
| Financing Cash Flow | 411.2 | 374.9 | 19.7 | 1.2 | 0.6 | 44.4 | 0.4 | (0.1) | 450.5 | (0.2) | 317.3 | (1.7) | 0 | 158.5 | 4.8 | (0.0) | 5 |
| Cash Position | |||||||||||||||||
| Net Change in Cash | 320.2 | 23.6 | (16.6) | 17.3 | (34.9) | 23.0 | (188.5) | (178.2) | 367.1 | (70.0) | 63.2 | (16.3) | (10.6) | 149.3 | 0 | (0.0) | 0 |
| Cash at Beginning | 131.5 | 107.9 | 124.5 | 107.2 | 142.1 | 119.1 | 307.6 | 485.5 | 118.3 | 188.3 | 125.1 | 141.3 | 151.9 | 2.6 | 0 | 5 | 0 |
| Cash at End | 451.8 | 131.5 | 107.9 | 124.5 | 107.2 | 142.1 | 119.1 | 307.3 | 485.5 | 118.3 | 188.3 | 125.1 | 141.3 | 151.9 | 0 | 5.0 | 0 |
| Free Cash Flow | (55.6) | (62.8) | (54.3) | (62.8) | (52.8) | (67.7) | (43.3) | (29.4) | (32.0) | (29.9) | (19.9) | (14.6) | (10.6) | (9.2) | (7.2) | 0 | 0 |
| Key Metrics | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.4) | 0.4 | (0.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (82.8) | (78.1) | (71.3) | (73.2) | (63.1) | (75.9) | (58.7) | (44.1) | (38.2) | (37.2) | (24.3) | (18.9) | (12.7) | (14.1) | (10.5) | (1.8) | (4.3) |
| Net Income | (74.1) | (69.4) | (65.0) | (66.1) | (55.3) | (67.2) | (49.0) | (33.8) | (32.1) | (31.7) | (20.8) | (18.9) | (12.5) | (14.0) | (19.7) | (1.8) | (4.3) |
| EPS (Diluted) | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.22 | -0.86 | -0.60 | -0.64 | -0.63 | -0.41 | -0.37 | -0.25 | -0.28 | -0.39 | -0.04 | -0.09 |
| Balance Sheet | |||||||||||||||||
| Cash & Equivalents | 451.8 | 131.5 | 107.9 | 124.2 | 106.9 | 141.8 | 118.8 | 307.3 | 485.5 | 118.3 | 188.3 | 125.1 | 141.3 | 151.9 | |||
| Total Assets | 1,293.7 | 937.1 | 626.2 | 657.8 | 714.2 | 754.0 | 776.3 | 800.7 | 823.7 | 401.4 | 426.4 | 130.7 | 142.0 | 152.1 | |||
| Total Debt | 8.0 | 8.8 | 9.9 | 10.8 | 11.8 | 11.8 | 12.1 | 4.1 | 1.8 | 2.0 | 0 | 0 | 0 | 0 | |||
| Stockholders' Equity | 1,255.8 | 903.9 | 586.3 | 619.4 | 673.4 | 716.8 | 734.4 | 773.6 | 801.5 | 379.9 | 409.2 | 113.1 | 130.8 | 142.1 | |||
| Cash Flow | |||||||||||||||||
| Operating Cash Flow | (55.6) | (62.7) | (54.3) | (62.0) | (48.5) | (67.7) | (42.5) | (29.3) | (31.6) | (29.8) | (19.9) | (14.6) | (10.6) | (9.2) | (7.2) | 0 | 0 |
| Capital Expenditure | 0 | (0.1) | 0 | (0.8) | (4.3) | 0.0 | (0.8) | (0.1) | (0.4) | (0.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | (55.6) | (62.8) | (54.3) | (62.8) | (52.8) | (67.7) | (43.3) | (29.4) | (32.0) | (29.9) | (19.9) | (14.6) | (10.6) | (9.2) | (7.2) | 0 | 0 |